OptimizeRx saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96. Is OptimizeRx stock on your watchlist? The new score indicates OptimizeRx is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria.
Read More